Table 1 Baseline demographics, clinical chemistry and interval between symptom onset and baseline presentation.
Variable | POCT (n = 218) | Controls (n = 151) |
|---|---|---|
n (%) or mean ± SD | n (%) or mean ± SD | |
Men | 121 (57.9) | 83 (58.0) |
Age [years] | 65 ± 16 | 64 ± 17 |
Weight [kg] | 80 ± 17 | 78 ± 17 |
Height | 169 ± 10 | 169 ± 9 |
Body mass index [kg/m2] | 28 ± 5 | 27 ± 6 |
Glucose [mmol/l] | 5.9 ± 1.5 | 6.3 ± 2.1 |
Creatinine [mmol/l] | 84.4 ± 29.1 | 84.4 ± 22.4 |
High-density lipoprotein [mmol/l] | 1.4 ± 0.7 | 1.4 ± 0.5 |
Low-density lipoprotein [mmol/l] | 2.9 ± 1.0 | 3.3 ± 1.0 |
Triglycerides [mmol/l] | 1.7 ± 1.1 | 1.7 ± 1.0 |
Interval between symptom onset and baseline visit [all patients, days] | 3.3 ± 9.8 | 1.7 ± 1.7 |
Interval between symptom onset and baseline visit [patients presenting <5 days after symptom onset, days] | 1.2 ± 1.4 (n = 185) | 1.5 ± 1.4 (n = 141) |